Home › Funds › ORBIMED ADVISORS LLC › EW

ORBIMED ADVISORS LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

ORBIMED ADVISORS LLC reported holding 834,900 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$75.5M, representing 1.52% of its reported portfolio and ranking #16 among its reported holdings. ORBIMED ADVISORS LLC has disclosed EW holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)834.90K sh
Reported value held$75.53M
Portfolio Weight1.52%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's EW position evolved

ORBIMED ADVISORS LLC first disclosed a stake in EW in Q4 2024 at 1,145,302 shares (US$84.8M). The position peaked in Q2 2025 at 1,708,000 shares, worth US$133.6M. Across 7 filings, ORBIMED ADVISORS LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 834,900 shares valued at US$75.5M — a reduction of -395,700 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2025 (shares rose 8% over the following quarter), a 91% trim in Q4 2025 (shares fell 6% over the following quarter), a 720% increase in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.15M $84.79M New
Q1 2025 1.53M $111.04M Add
Q2 2025 1.71M $133.58M Add
Q3 2025 1.68M $130.96M Reduce
Q4 2025 150.00K $12.79M Reduce
Q1 2026 1.23M $98.55M Add
Q2 2026 834.90K $75.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held EW?

ORBIMED ADVISORS LLC has disclosed EW holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is ORBIMED ADVISORS LLC's current position in EW?

As of Q2 2026, ORBIMED ADVISORS LLC holds 834.90K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $75.53M, representing 1.52% of its reported portfolio and ranking #16.

Has ORBIMED ADVISORS LLC been buying or selling EW?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in EW. The position peaked in Q2 2025 at 1.71M shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.